Discontinuation of Antiplatelet Treatment and Risk of Recurrent Stroke and All-Cause Death: A Cohort Study

Publisher： Karger

E-ISSN： 1423-0208|43|1|57-64

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.43, Iss.1, 2014-10, pp. : 57-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discontinuation of Antiplatelet Study Medication and Risk of Recurrent Stroke and Cardiovascular Events: Results from the PRoFESS Study

By  

Cerebrovascular Diseases, Vol. 35, Iss. 6, 2013-06 ,pp. : 538-543

Karger

Access to resources Recommend Favorite

Lifestyle Changes in Young Adulthood and Middle Age and Risk of Cardiovascular Disease and All‐Cause Mortality: The Doetinchem Cohort Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 1, 2016-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased Carotid Intima-Media Thickness and Plasma Homocysteine Levels Predict Cardiovascular and All-Cause Death: A Population-Based Cohort Study

By  

European Neurology, Vol. 70, Iss. 1-2, 2013-04 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Risk Factors and Treatment at Recurrent Stroke Onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study

By  

Cerebrovascular Diseases, Vol. 25, Iss. 3, 2008-01 ,pp. : 254-260

Karger

Access to resources Recommend Favorite

Antihypertensive Treatment after Stroke and All-Cause Mortality – An Analysis of the General Practitioner Research Database (GPRD)

By  

Cerebrovascular Diseases, Vol. 28, Iss. 2, 2009-06 ,pp. : 105-111

Karger

Access to resources Recommend Favorite